SILO Pharma Inc’s filing revealed that its Chief Executive Officer Weisblum Eric acquired Company’s shares for reported $4329.0 on May 27 ’25. In the deal valued at $0.43 per share,10,000 shares were bought. As a result of this transaction, Weisblum Eric now holds 197,932 shares worth roughly $0.11 million.
Then, Weisblum Eric bought 2,500 shares, generating $2,097 in total proceeds. Upon buying the shares at $0.84, the CEO and President now owns 187,932 shares.
Before that, Weisblum Eric bought 2,500 shares. SILO Pharma Inc shares valued at $2,375 were divested by the CEO and President at a price of $0.95 per share. As a result of the transaction, Weisblum Eric now holds 182,932 shares, worth roughly $0.11 million.
Price Performance Review of SILO
On Friday, SILO Pharma Inc [NASDAQ:SILO] saw its stock fall -7.13% to $0.58. Over the last five days, the stock has lost -5.18%. SILO Pharma Inc shares have fallen nearly -32.30% since the year began. Nevertheless, the stocks have fallen -34.42% over the past one year. While a 52-week high of $4.50 was reached on 01/08/25, a 52-week low of $0.41 was recorded on 05/22/25.
Levels Of Support And Resistance For SILO Stock
The 24-hour chart illustrates a support level at 0.5476, which if violated will result in even more drops to 0.5115. On the upside, there is a resistance level at 0.6549. A further resistance level may holdings at 0.7261.
How much short interest is there in SILO Pharma Inc?
A steep rise in short interest was recorded in SILO Pharma Inc stocks on 2025-06-13, dropping by -0.66 million shares to a total of 0.8 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 1.46 million shares. There was a decline of -81.84%, which implies that there is a negative sentiment for the stock.
